Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Interpace Biosciences Inc IDXG

Healthcare
Interpace Biosciences, Inc. provides personalized medicine and offers specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services, through Interpace Diagnostics, provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating the risk of cancer by... see more

Recent & Breaking News (OTCQX:IDXG)

Interpace Biosciences Announces Contract with Lab Benefits Management Firm

GlobeNewswire April 27, 2020

Interpace Biosciences Announces Full Year and Fourth Quarter 2019 Financial and Business Results and Preliminary Q1-2020 Results

GlobeNewswire April 22, 2020

Interpace Biosciences to Host Conference Call and Webcast to Discuss Fourth Quarter, Full Year 2019 and Preliminary First Quarter 2020 Financial Results on Wednesday, April 22, 2020

GlobeNewswire April 22, 2020

Interpace Diagnostics Issues Update Regarding Announced Contract with BCBS of Massachusetts

GlobeNewswire March 11, 2020

Interpace Diagnostics Announces Contract with BCBS of Massachusetts

GlobeNewswire March 10, 2020

Interpace Biosciences Announces Acceptance of first paper Demonstrating Clinical Performance of ThyGeNEXT with ThyraMIR

GlobeNewswire March 2, 2020

Interpace Announces Extension of LabCorp Agreement

GlobeNewswire February 24, 2020

Interpace Biosciences Announces Another Pricing improvement for its Thyroid Assay

GlobeNewswire February 11, 2020

Interpace Biosciences Announces Addition to Board of Directors and Changes in Leadership

GlobeNewswire January 30, 2020

Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners

GlobeNewswire January 13, 2020

Interpace Biosciences Announces Collaborative Study with University of North Carolina to Assess the Use BarreGEN® after Ablation of Dysplastic Barrett's Esophagus

GlobeNewswire January 6, 2020

Interpace Biosciences Announces New Draft LCD and Reimbursement for Its Proprietary Thyroid Assay, ThyGeNEXT®

GlobeNewswire December 17, 2019

Interpace Biosciences Expands Strategic Partnership Activities with Genecast Biotechnology in China

GlobeNewswire December 5, 2019

Interpace Biosciences Launches New Corporate Website

GlobeNewswire December 2, 2019

Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results

GlobeNewswire November 13, 2019

Interpace to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results on Wednesday, November 13, 2019

GlobeNewswire November 12, 2019

Interpace Diagnostics Announces Publication of New Data on Thyroid Test Utility

GlobeNewswire November 4, 2019

Interpace to Present Data at the ATA Annual Meeting

GlobeNewswire October 29, 2019

Cancer Genetics, Inc. Announces Strategic Transactions

GlobeNewswire October 24, 2019

Interpace to Present at the American College of Gastroenterology Conference

GlobeNewswire October 24, 2019